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Abstract 
A rapid, precise, accurate, specific and simple RP-HPLC method was developed for the estimation of 
Abacavir in bulk and in tablet dosage form. A High performance liquid chromatograph 10AT 
SHIMADZU- SPD10A, using Phenomenex - Luna RP-18(2),250X4.6mm, 5 µm column, with a 
mobile phase composed  from water: Acetonitrile [80:20 %(v/v)] were used. The flow rate of 1.0 
ml/min and the effluent was detected at 285 nm by using a UV detector. The retention time of 
Abacavir was 7.761 min. Linearity was observed over concentration range of 100-2800 ng ml-1. The 
Limit of detection was found to be 21.04 ng ml-1while quantification limit was 63.77 ng ml-1. The 
accuracy of the proposed method was determined by recovery studies and found to be 98.23 to 100.61 
%. Commercial tablet formulation was successfully analyzed using the developed method and the 
proposed method is applicable to stability studies and routine analysis of Abacavir in bulk and 
pharmaceutical formulations. 
The proposed method was validated for various ICH parameters like linearity, limit of detection, 
limits of quantification, accuracy, precision, range and specificity. 
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1. Introduction 
Abacavir is chemically [(1R)-4-[2-amino-6-
(cyclopropylamino) purin-9-yl]-1-cyclopent-2-
enyl] methanol (Fig. 1). It is a white crystalline 
powder used as antiretroviral agents, for the 
treatment of HIV infection. Abacavir belongs to 
a class of antiretroviral drugs known as 
nucleoside reverse transcriptase inhibitor 
(NRTI) with activity against Human 
Immunodeficiency Virus Type 1 (HIV-1)1. 
Literature survey reveals that very few analytical 
methods has been established for the 
determination of abacavir viz. abacavir, 
lamivudine and zidovudine in Pharmaceutical 
Tablets, Human Serum and in Drug Dissolution 
Studies by HPLC2, Hypersensitivity reaction to 
abacavir is strongly associated with the presence 
of the HLA-B*5701 allele3, Simple and Reliable 
HPLC Method of Abacavir Determination in 
Pharmaceuticals, Human Serum and Drug 
Dissolution Studies from Tablets4, 
Spectrophotometric determination of abacavir 
sulphate5, RP-HPLC Method for the 
simultaneous Estimation of Lamivudine and 
Abacavir Sulphate in Tablet Dosage Form6, 
Development and Validation of RP-HPLC 
Method for the Estimation of Abacavir , 
Lamivudine and Zidnovudine in Pharmaceutical 
Dosage Form7, Spectrophotometric Estimation 
of Abacavir Sulphate in Bulk and Tablet Dosage 
Form8, Visible spectrophotometric 
determination of Abacavir sulphate in Bulk 
Drug and Tablet Dosage Form9.  
  Fig. 1: Chemical structure of Abacavir 
 
The stability of a drug substance or drug 
product is defined as its capacity to remain 
within established specifications, i.e. to 
maintain its identity, strength, quality, and 
purity until the retest or expiry date10. Stability 
testing of an active substance or finished 
product provides evidence of how the quality of 
a drug substance or drug product varies with 
time under a variety of environmental 
conditions, for example temperature, humidity, 
and light. Knowledge from stability studies is 
used in the development of manufacturing 
processes, selection of proper packaging and 
storage conditions, and determination of product 
shelf-life11-12. There was no reported stability-
indicating analytical method for analysis of 
abacavir in the presence of its degradation 
products in bulk and pharmaceutical dosage 
forms. The objective of this work was to 
develop a new, simple, economic, rapid, 
precise, and accurate stability-indicating HPLC 
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method for quantitative analysis of abacavir, 
and to validate the method in accordance with 
ICH guidelines13 with shorter retention time, 
runtime, and economic mobile phase. 
2. Experimental 
2.1 Materials and Methods: Pure standard of 
Abacavir (Assigned purity 99.97%) was 
obtained as a gift sample from Ranbaxy labs 
Pvt. Ltd, Jammu (H.P). The gift samples were 
used as standard without further purification. 
HPLC grade water, CH3CN (Acetonitrile) and 
CH3OH were purchased from (Qualigens), HCl, 
NaOH, H2O2 were purchased from (S.D. fine 
chemicals, Mumbai, India), and were used 
throughout the experiment. Commercial 
pharmaceutical preparation which was received 
from (Ziagen) which was claimed to contain 
300mg of Abacavir is used in the analysis. The 
chemical structure and purity of the sample 
obtained was confirmed by TLC, IR, Melting 
point studies. 
2.2 Instrumentation and Chromatographic 
conditions: High performance liquid 
chromatograph with Shimadzu pumpLC-10AT 
VP equipped with universal injector (Hamilton 
25 µL) SPD10A and a UV-VIS detector 
SPD10A-10A VP (Shimadzu) was used. 
Isocratic elution of mobile phase composed of 
water and Acetonitrile in the ratio of 80:20 % 
(v/v) with flow rate of 1.0 ml/min was 
performed on C18 column (250x 4.6 mm, 5µm). 
The effluent was detected at 285 nm. The 
retention time of Abacavir was 7.761 min. The 
column temperature was maintained at ambient 
and the volume of injection was 20 µl. Prior to 
injection of the analyte, the column was 
equilibrated for 30- 40 min with mobile phase.  
Different kinds of equipments viz Analytical 
weighing balance (Shimadzu AX 200), 
Sonicator (model SONICA 2200MH), Water 
purification system, Vacuum pump (model XI 
5522050 of Millipore), Millipore filtration kit 
for solvents and sample filtration were used 
throughout the experiment. The Spinchrom CFR 
software was used for acquisition, evaluation 
and storage of chromatographic data. 
2.3 Preparation of Mobile phase: The HPLC 
grade solvents of water and Acetonitrile were 
used for the preparation of mobile phase in the 
ratio of 80:20 % (v/v). The contents of the 
mobile phase were filtered before use through a 
0.45µm membrane filter, sonicated and pumped 
from the solvent reservoir to the column at a 
flow rate of 1 ml/min. 
2.4 Preparation of Standard Solution: A stock 
solution of the drug was prepared by dissolving 
100 mg of Pure Abacavir in a 100 ml volumetric 
flasks containing sufficient amount of methanol 
(HPLC grade) to dissolve the drug, sonicated for 
about 15 min and then made up to volume with 
mobile phase. Daily working standard solutions 
of Abacavir was prepared by suitable dilution of 
the stock solution with the mobile phase. Six 
sets of the drug solution were prepared in the 
mobile phase containing Abacavir at a 
concentration of 600-1600ng/ml. Each of these 
drug solutions (20µl) was injected six times into 
the column, the peak area and retention times 
were recorded.  
2.4.1 Procedure for sample solution 
preparation (from Formulation): Twenty 
tablets were weighed accurately and powdered. 
An amount of the powder equivalent to 300 mg 
of Abacavir (content of one tablet) was 
dissolved in 50 ml of the mobile phase. The 
solution was stirred for 10 min using a magnetic 
stirrer and filtered into a 100 ml volumetric flask 
through 0.45 µm membrane filter. The residue 
was washed 3 times with 10 ml of mobile phase, 
and then the volume was completed to 100 ml 
with the same solvent. Further addition of the 
mobile phase was performed to obtain a stock 
solution of 10 µg/ml. An aliquot of this solution 
(1 ml) was transferred to a 10 ml volumetric 
flask and a sufficient volume of the mobile 
phase was added to give an expected 
concentration of 1 µg/ml. All determinations 
were conducted in triplicate. 
2.5 Stability Studies 
2.5.1 Thermal degradation at different 
temperature and different time interval: Expose 
about 2 to 3 g of drug sample (Bulk drug and 
Tablet dosage form) at different time intervals 
viz. 0, 90, and 180 days and at different 
temperatures viz.-200C, 250C, and 400C.The drug 
sample solution (Abacavir) in mobile phase was 
demonstrated by injecting the sample solution in 
HPLC, no degradants were observed in the 
chromatogram. However, after 180 days and 
400C the chromatographic peak area of abacavir 
decreased insignificantly. Hence, the sample was 
stable at least for 180 days at 400C (The temp. 
can be maintained by using freezer and oven).  
2.5.2 Photochemical Degradation: The 
photochemical stability of the abacavir was 
studied by exposing the methanolic stock 
solution to direct sunlight for 8 h (from 9 AM to 
5 PM, 20±5oC). 
2.5.3 Thermal stress (test sample exposed to 
sunlight): Transfer about 2 to 3 g of drug 
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sample (Bulk drug and Tablet dosage form) into 
a clean dry watch glass and spread evenly. 
Expose to sunlight for 10 hours. After the 
sample got exposed to prescribed time, weigh 
accurately 25 mg of sample into a clean dry 50 
ml volumetric flask, dissolve and dilute to the 
mark with mobile phase, finally make a 
concentration of 1000ng/ml with mobile phase 
and inject 20µl of this sample into HPLC, 
observe the degradation. 
2.5.4 Forced degradation of Abacavir and 
tablets of Abacavir: In order to establish 
whether the analytical method and the assay 
were stability indicated, the tablets and pure 
active pharmaceutical ingredient of abacavir 
were stressed under various conditions to 
promote degradation. As this drug was freely 
soluble and stable in methanol and this solvent 
was used as solvent in all forced degradation 
studies. All solutions were prepared to use in 
forced degradation studies were prepared by 
dissolving Abacavir or drug product in small 
amount of methanol and later diluted with 3% 
hydrogen peroxide, 0.1N hydrochloric acid and 
0.1 N sodium hydroxide to achieve 
concentration of 100µg/ml After the 
degradation, these solutions were diluted with 
mobile phase to get starting concentration of 
10µg/ml with the objective of evaluating 
stability of abacavir. The degradants were 
observed in the chromatogram and showing 
good resolution from the abacavir. 
2.5.5 Hydrolysis (Acid and Alkali): Initially for 
hydrolytic degradation the abacavir was 
dissolved in known amount of methanol and 
diluted with 0.1N HCl or 0.1N NaOH to obtain a 
concentration of 100µg/ml. After completion of 
degradation process, both the solutions were 
neutralized with acid or base, as necessary and 
diluted with the mobile phase to achieve a 
concentration of 10µg/ml. The solutions for 
hydrolysis were prepared in methanol and 0.1 N 
HCl and 0.1N NaOH (60:40 v/v). The prepared 
acidic and alkali solutions were injected to the 
chromatographic system at 0 h (immediately 
after preparing the solution) and after reflux at 
60 0c about 2 h. The respective chromatograms 
were recorded for the study of extent of 
degradation. 
2.5.6 Peroxide Degradation: The solutions for 
peroxide degradation were prepared in methanol 
and 3% hydrogen peroxide (60:40 v/v). The 
prepared solution was refluxed at 60 0c about 2 h 
and injected into chromatographic system after 2 
h. The respective chromatogram was recorded 
for the study of extent of degradation. 
 
3. Results and Discussion 
3.1 Stability Studies: 
3.1.1 Thermal degradation at different 
temperature and different time intervals: 
Expose about 2 to 3 gm of drug sample (Bulk 
drug and Tablet dosage form) at different time 
intervals viz. 0, 90, and 180 days and at different 
temperatures viz.-200 C, 250 C, and 400 C.The 
drug sample solution (Abacavir) in mobile phase 
was demonstrated by injected the sample 
solution in HPLC, no degradants were observed 
in the chromatogram. However, after 180 days 
and 400C the chromatographic peak area of 
abacavir decreased insignificantly. Hence, the 
sample was stable at least for 180 days at 400C. 
(The temp. can be maintained by using freezer 
and oven). (Chromatogram no.1-8) 
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                                 Stability Chromatogram No. 3 (250C, 90 Days) 
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                              Stability Chromatogram No. 6 (-200C, 180 Days) 
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                               Stability Chromatogram No. 7 (400C, 90 Days) 
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Stability Chromatogram No. 8 (400C, 180 Days) 
 
The result obtained by thermal degradation at 
different temperature and different time interval 
viz. Initial, 250C at 90days, 250C at 180days, -
200C at 90days, -200C at 180days, 400C at 
90days, 400C at 180days was found to be 
99.62%, 99.46%, 99.02%, 99.54%, 99.39%, 
98.06%, 97.23% respectively. Further study was 
carried out by employing the following tests: 
hydrolysis (neutral, acidic and basic), photolysis 
and thermolysis. No decomposition was 
observed when the abacavir was exposed to 
sunlight, temperature, UV. A significant change 
was observed as a decrease of assay of about 20 
to 25 % when the sample was treated with 0.1 N 
NaOH and 0.1 N HCl. The sample which was 
treated with 3 % H2O2 was almost completely 
degraded. 
3.2 Validation of analytical Method: Analytical 
validation is the corner stone of process 
validation without a proven measurement system 
it is impossible to confirm whether the 
manufacturing process has done what it purports 
to do.  All new developed methods should be 
validated by using these parameters (According 
to ICH guidelines).  
1. Linearity  
2. Accuracy 
3. Precision 
4. Specificity 
5. Limit of detection 
6. Limit of quantification 
7. Range  
8. Ruggedness 
9. Robustness 
10. System suitability 
11. Solution stability 
3.2.1  Linearity 
Acceptance criteria: For linearity the 
Coefficient of correlation value (r2) should be 
greater than 0.998 (Regression value in linear 
plot). 
Procedure: A stock solution of drug was 
prepared by dissolving 100 mg of pure Abacavir 
in a 100 ml volumetric flasks containing 
sufficient amount of methanol (HPLC grade) to 
dissolve the drug, sonicated for about 15 min 
and then made up to volume with mobile phase. 
Daily working standard solutions of Abacavir 
was prepared by suitable dilution of the stock 
solution with the mobile phase. Six sets of the 
drug solution were prepared in the mobile phase 
containing abacavir at a concentration of 600-
1600ng/ml. Each of these drug solutions (20µl) 
was injected in six concentrations in three 
replicates times into the column, the peak area 
and retention times were recorded. (Table No. 1 
and chromatogram No. 9) 
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Table no. 1: Peak Area* of Abacavir: 
Replicate Dilution 
I 
Dilution 
II 
Dilution 
III 
Dilution 
IV 
Dilution 
V 
Dilution 
VI 
1 8496377 9445587 10629587 11752141 12762178 13826313 
2 8501452 9582471 10596328 11786254 12871521 13925411 
3 8482517 9571968 10632596 11769851 12763652 13852137 
Average 8493449 9533342 10619504 11769415 12799117 13867954 
SD 9801.271 76179.284 20127.026 17060.673 62708.034 51407.476
RSD% 0.12 0.80 0.19 0.14 0.49 0.37 
*Average of five readings 
 
                              Chromatogram No. 9 (Overlay spectra for Linearity) 
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Correlation coefficient (r2) for abacavir was 
found to be 0.9998, indicating that the linearity 
and the method is linear between the 
concentrations of 100-2800ng mL-1. 
3.2.2 Accuracy: The accuracy is the closeness of 
the measured value to the true value for the 
sample. Accuracy was found out by recovery 
study from prepared solution (three replicates) 
with standard solution, of the label claim. 
Aliquots of 0.2 ml, 0.4ml and 0.8 ml of sample 
drug (Abacavir) solution of 10µg/ml were 
pipetted into each of three volumetric flasks. To 
this 0.4 ml of standard drug (Abacavir) solution 
of 10 µg/ml was added to each volumetric flask 
respectively. The volume was made up to 10 ml 
with mobile phase. 20 µl of each solution was 
injected and chromatograms were recorded. The 
range was found between 98.234 to 100.615 % 
respectively The values of recovery justify the 
accuracy of the method. The % recovery values 
were obtained within the standard limit which 
confirms that the method is accurate and free 
from any positive or negative interference of the 
excipients.    
The recovery data was generated for Abacavir 
are presented in the Table No.2
Table No. 2: 
Conc. taken in ng/ml 
( A) 
Std addition in ng/ml 
( B) 
Total drug conc. in ng/ml 
( A+B ) 
Peak   
Area* 
% 
Recovery 
200 400 600 8545711 100.615 
400 400 800 9562549 100.306 
800 400 1200 11561673 98.234 
  *Average of three readings 
The percentage recovery by the proposed 
method was ranging from 98.23 to 100.61 % 
indicating no interference of the tablet excipients 
with drug under analysis. 
3.2.3 Precision Precision is measure of 
repeatability or reproducibility and it was 
determined by injecting 5 times the expected 
operating range concentration. The 
chromatograms were recorded to determine 
mean standard deviation and relative standard 
deviation. 
Acceptance criteria: For precision the Relative 
standard deviation (RSD) should be less than 
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2.0% (RSD<2.0%) for peak area and retention 
time. 
Table No.3 (Precision of Abacavir) 
S.No. Area Response 
1. 9749901 
2. 9693755 
3. 9683955 
4. 9650582 
5. 9652257 
Average 9686090 
S.D 40437.124 
R.S.D 0.42 
From the above analytical data it is observed 
that RSD value for the assay is 0.42% which 
indicates that the method is precise and 
reproducible (According to ICH guidelines). 
3.2.3 Specificity: Specificity is the ability to 
assess the analyte in the presence of components 
that may be expected to be present in the sample 
matrix (USP 2004). For demonstrating the 
specificity of the method for drug formulation 
the drug was spiked and the representative 
chromatogram (chromatogram No. 10).  
 
Chromatogram of Abacavir showing Specificity (chromatogram No. 10) 
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The excipients used in different formulation 
products did not interfere with the drug peak and 
thus, the method is specific for abacavir.  
3.2.4 Solution Stability: The solution stability of 
the standard and sample that prepared in mobile 
phase was studied for 5 days at bench top. The 
solution under study was compared with freshly 
prepared standard solution. The samples were 
found to be stable for period of more than 72 
hours. 
3.2.5 Range: The range was calculated from the 
linearity graph. The specific range can be 
obtained from linearity graph. The range which 
is linear, accurate and precise between lower and 
higher concentration is the beer’s range of the 
method 
The range for abacavir was found to be 100-
2800ng/ml. 
3.2.6 Limits of detection and quantification: 
The limit of detection (LOD) is the lowest 
amount of an analyte in a sample that can be 
detected, but not necessarily quantized under the 
stated experimental conditions. It may be 
expressed as a concentration that gives a signal-
to-noise ratio of 2:1 or 3:1. The lower limit of 
detection for abacavir is 21.04 ng/ml in 
reference material and formulation. Limit of 
Quantification (LOQ) is the lowest amount 
analyte in a sample that can be determined with 
acceptable precision and accuracy under the 
stated experimental conditions. A signal-to-noise 
ratio of 10:1 can be taken as LOQ of the method. 
The LOQ values were found to be 63.77 ng/ml 
for raw material and formulations. 
3.2.7 System suitability: A stock solution of 
abacavir (Approx. 800ng mL-1) was prepared in 
the mobile phase and injected in the system in 
five replicates, after obtaining the chromatogram 
the system suitability parameters were calculated 
(Chromatogram No. 11). 
3.2..8 Theoretical plates per column: Number 
of theoretical plates in the column were 
calculated from the data obtained from the peak. 
                                      n = (5.54Vr2)/Wh2 
Where, ‘n’ is number of theoretical plates per 
length, ‘Vr’ is the distance along the base 
line between the point of injection and a 
perpendicular dropped from the maximum of 
the peak of interest (retention time) and ‘Wh’ 
is the width of the peak of interest at half 
peak height.   
3.2.9 Tailing Factor (USP Method): A measure 
of the symmetry of a peak, given by the 
following equation, where W0.05 is the peak 
width at 5% height and f is the distance from 
peak front to apex point at 5% height. Ideally, 
peaks should be Gaussian in shape or totally 
symmetrical. 
T = W0.05 / 2f  
The accuracy of quantization decreases with 
increase in peak tailing because of the 
difficulties encountered by the integrator in 
determining where/when the peak ends and as a 
result the calculation of the area under the peak. 
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Integrator variables are preset by the analyst for 
optimum calculation of the area for the peak of 
interest. 
Recommendations: 
T of ≤ 2                 
T= (a+b) / 2a   
 Where:  T = tailing factor (measured at 5% of 
peak height) 
b = distance from the point at peak midpoint to 
the trailing edge  
                 a = distance from the leading edge of 
the peak to the midpoint  
Table4. Resultss of system suitability 
parameters 
Parameters Data obtained 
Abacavir 
Theoretical plates per column 4632 
Symmetry factor/Tailing 
factor 
1.12 
Chromatogram No. 11(showing system suitability) 
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Conclusion 
The proposed RP-HPLC method is found to be 
accurate, precise, linear, stable, specific, and 
simple, for quantitative estimation of Abacavir 
in raw material and pharmaceutical 
formulations. Hence the present RP-HPLC 
method is suitable for routine assay of abacavir 
in raw materials and in pharmaceutical 
formulations in the quality control laboratories.  
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